IP Library › Granted Patent US 7,678,143
Granted Patent B2
US 7,678,143 · App. 10/712,678 · Granted Mar 16, 2010

Ethylene-carboxyl copolymers as drug delivery matrices

Assignee: Advanced Cardiovascular Systems, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,678,143
App. No.
10/712,678
Granted
Mar 16, 2010
Kind
B2
Abstract

A coated stent is provided including a coating composed of one or more co-polymers of ethylene with carboxylic acid wherein the carboxylic acid co-monomer content is 5-50 wt %.

Claims (13)

1. A method of coating an implantable medical device, comprising:

adding a copolymer of an ethylene comonomer with a carboxylic acid comonmer to a solvent system to form a composition;

mixing a therapeutic drug with the copolymer composition to allow the drug uniformly dispersed in the copolymer composition, wherein the drug concentration is 5% to 20% by weight;

applying the composition to an implantable medical device; and

allowing the solvent system to evaporate;

wherein the carboxylic acid comonomer content is 5%-50 wt %.

2. The method of claim 1 , wherein the carboxylic acid comonomer is selected from a group consisting of acrylic acid, methacrylic acid, maleic acid, itaconic acid, and esters thereof.

3. The method of claim 1 , wherein adding the copolymer to the solvent system further comprises neutralizing the copolymer in a volatile or a non-volatile base and dispersing the copolymer in water and/or a co-solvent.

4. The method of claim 1 , wherein the solvent system comprises toluene.

5. The method of claim 4 , wherein the solvent system further comprises a chlorinated solvent and a lower alcohol.

6. The method of claim 1 , wherein the carboxylic acid co-monomer has a content in the copolymer 15% to 40% by weight.

7. The method of claim 1 , wherein the co-polymer is ethylene acrylic acid.

8. The method of claim 1 , wherein the device comprises a stent.

Continuity (2)
Division 0974871900 · Dec 22, 2000
Related Publication 20040096504A1 · May 20, 2004